Using 18F-ML-10 PET/CT imaging to detect atherosclerosis lesions and apoptotic processes in mice

Lifang Pang1,2,3, Guobing Liu1,2,3, Yan Hu1,2,3

  • 1Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Abstract

Insights

Positron emission tomography (PET) imaging with 18F-ML-10 effectively visualizes apoptotic activity in atherosclerotic plaques. This technique shows increased plaque uptake in advanced atherosclerosis, correlating with cell death markers.

Area of Science:

  • Cardiovascular Research
  • Molecular Imaging
  • Biomedical Engineering

Background:

  • Apoptosis is a key factor in atherosclerotic plaque development and progression.
  • 18F-ML-10 is a novel PET radiotracer targeting apoptotic cells via membrane alterations.

Purpose of the Study:

  • To evaluate the efficacy of 18F-ML-10 PET/CT for visualizing apoptotic activity in atherosclerotic plaques.
  • To correlate imaging findings with established markers of atherosclerosis and apoptosis.

Main Methods:

  • Apolipoprotein E knockout (ApoE-/-) mice on a high-fat diet were imaged at 20 and 32 weeks.
  • 18F-ML-10 PET/CT was performed, followed by Oil-red-O, H&E, TUNEL, and caspase-3 staining.
  • Plaque-to-background (P/B) ratios were correlated with lipid deposition and apoptosis indices.

Main Results:

  • 18F-ML-10 PET/CT demonstrated significantly higher P/B ratios in ApoE-/- mice at 32 weeks compared to 20 weeks (2.28 vs 1.69, P=0.002).
  • Increased lipid deposition and apoptosis (TUNEL, caspase-3) were observed from 20 to 32 weeks.
  • P/B ratios strongly correlated with apoptosis markers (r=0.950 for TUNEL, r=0.955 for caspase-3).

Conclusions:

  • 18F-ML-10 PET/CT is a viable imaging technique for visualizing atherosclerotic plaques with high apoptotic cell content.
  • The tracer shows promise for non-invasively assessing plaque activity and progression.

Related Concept Videos